C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 249/08 (2006.01) A61K 31/4196 (2006.01) A61P 11/06 (2006.01) C07D 405/10 (2006.01)
Patent
CA 2552871
The invention relates to the use of compounds of formula (I), in which the groups R1, R2, R3, R4 and n can be defined as cited in the claims and the description, for producing a medicament for the treatment of inflammatory and obstructive respiratory tract diseases. The invention also relates to novel compounds of formula (I) per se.
La présente invention concerne les composés de la formule (I) où les groupes R?1¿, R?2¿, R?3¿, R?4¿ et n peuvent avoir les significations données dans les revendications et dans la description. L'invention concerne notamment l'utilisation de ces composés pour la production d'un médicament destiné au traitement de syndromes obstructif et inflammatoire des voies respiratoires, ainsi que de nouveaux composés de la formule (I) en tant que tels.
Bouyssou Thierry
Hoenke Christoph
Konetzki Ingo
Mack Juergen
Schnapp Andreas
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Novel, sustained-action beta-2-agonists and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel, sustained-action beta-2-agonists and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel, sustained-action beta-2-agonists and their use as... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1381042